Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer

Cancer Research

Volumn 60, Issue 11, 2000, Pages 3081-3087

  Tang, Careen K ^a   Gong, Xiao Qi ^a   Moscatello, David K ^b   Wong, Albert J ^b   Lippman, Marc E ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; DNA, COMPLEMENTARY; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034214087     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Salomon, D. S., Brandi, R., Ciardiello, F., and Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19: 183-232, 1995.
2. Akiyama, T., Kadooka, T., and Ogawara, H. Purification of the epidermal growth factor receptor by tyrosine-Sepharose affinity chromatography. Biochem. Biophys. Res. Commun., 131: 442-448, 1985.
3. Besmer, P., Murphy, J. E., George, P. C., Qiu, F., Bergold, P. J., Lederman, L., Snyder, H. W., Brodeur, D., Zuckerman, E. E., and Hardy, W. D. A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (Lond.), 320: 415-421, 1986.
4. Gullick, W. J. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancer cells. Br. Med. Bull., 47: 87-98, 1991.
5. Harris, A. L., Nicholson, S., Sainsbury, R., Wright, C., and Farndon, J., J. Epidermal growth factor receptor and other oncogenes as prognostic markers. Natl. Cancer Inst. Monogr., 11: 181-187, 1992.
6. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature (Lond.), 313: 144-147, 1985.
7. Berger, M. S., Greenfield, C., Gullick, W. J., Haley, J., Downward, J., Neal, D. E., Harris, A. L., and Waterfield, M. D. Evaluation of epidermal growth factor receptors in bladder tumors. Br. J. Cancer, 56: 533-537, 1987.
8. Ozanne, B., Richards, C. S., Hendler, F., Burns, D., and Gusterson, B. Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. J. Pathol., 149: 9-14, 1986.
9. Hynes, N. E., and Stern, D. F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochem. Biophys. Acta, 1198: 165-184, 1994.
10. Groenen, L. C., Nice, E. C., and Burgess, A. W. Structure-function relationships for the EGF/TGF-α family of mitogens. Growth Factors, 11: 235-257, 1994.
11. Di Fiore, P. P., Pierce, H. J., Fleming, T. P., Hazan, R., Ullrich, A., King, C. R., Schlessinger, J., and Aaroson, S. A. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell, 51: 1063-1070, 1987.
12. Velu, T. J., Beguinot, L., Vass, W. C., Willingham, M. C., Merlino, G. T., Paslan, I., and Lowy, D. R. Epidermal growth factor-dependent transformation by a human EGF receptor proto-oncogene. Science (Washington DC), 238: 1408-1410, 1987.
13. Ekstrand, A. J., Sugawa, N., James, C. D., and Collins, V. P. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc. Natl. Acad. Sci. USA, 89: 4309-4313, 1992.
14. Yamazaki, H., Fukui, Y., Ueyama, Y., Tamaoki, N., Kawamoto, T., Taniguchi, S., and Shibuya, M. A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Mol. Cell. Biol., 8: 1816-1820, 1988.
15. Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., and Vogelstein, B. Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. USA, 89: 2965-2969, 1992.
16. Humphrey, P. A., Wong, A. J., Vogelstein, B., Zalutsky, M. R., Fuller, G. N., Archer, G., Friedman, H. S., Kwatra, M. M., Bigner, S. H., and Bigner, D. D. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Proc. Natl. Acad. Sci. USA, 87: 207-4211, 1990.
17. Moscatello, D. K., Montgomery, R. B., Sundareshan, P., McDanel, H., Wong, M. Y., and Wong, A. J. Transformation and altered signal transduction by a naturally occurring mutant EGF receptor. Oncogene, 13: 85-96, 1996.
18. Chu, C. T., Everiss K. D., Wikstrand, C. J., Batra, S. K., Kung, H-J., and Bigner, D. D. Receptor dimerization is not a factor in the signaling activity of a transforming variant epidermal growth factor receptor (EGFRvIII). Biochem. J., 324: 855-861, 1997.
19. Ekstrand, A. J., Longo, N., Hamid, M. L., Olson, J. J., Liu, L., Collins, V. P., and James, C. D. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene, 9: 2313-2320, 1994.
20. Batra, S. K., Castelino-Prabhu, S., Wikstrand, C. J., Zhu, X., Humphrey, P. A., Friedman, H. S., and Bigner, D. D. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene. Cell Growth Differ., 6: 1251-1259, 1995.
21. Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G., Zoltick, P. W., Biegel, J. A., Hayes, R. L., and Wong, A. J. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res., 55: 5536-5539, 1995.
22. Garcia de Palazzo, I., Adams, G. P., Sundareshan, P., Wong, A. J., Testa, J. R., Bigner, D. D., and Weiner, L. M. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res., 53: 3217-3220, 1993.
23. Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, L., Humphrey, P. A., Kurpad, S. K., McLendon, R. E., Moscatello, D., Pegram, C. N., Reist, C. J., Traweek, T., Wong, A. J., Zalutsky, M. R., and Bigner, D. D. Monoclonal antibodies against EGFRvIII are tumor specific and react with hreast and lung carcinomas and malignant gliomas. Cancer Res., 55: 3140-3148, 1995.
24. Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G., Cavenee, W. K., and Su Huang, H-J. S. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA, 91: 727-7731, 1994.
25. Nagane, M., Coufal, F., Lin, H., Bogler, O., Cavenee, W. K., and Su Huang, H-J. A common mutant epidermal growth factor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res., 56: 5079-5086, 1996
26. Pierce, J. H. Signal transduction through foreign growth factor receptors. Adv. Regul. Cell Growth, 2: 275-297, 1990.
27. Carter, T. H., and Kung, J. H. Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor. Crit. Rev. Oncog., 5: 389-428, 1994.
28. Pierce, J. H., Ruggiero, M., Fleming, T. P., Di Fiore, P. P., Greenberger, J. S., Varticovski, L., Schlessinger, J. Rovera, G., and Aaroson, S. A. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science (Washington DC), 239: 628-630, 1988.
29. Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B. J., Sela, M., and Yarden, Y. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J., 15: 2452-2467, 1996.
30. Riese, D. J., II, van Raaij, T. M., Plowman, G. D., Andrews, G. C., and Stern, D. F. The cellular response to neuregulins is governed by complex interactions of the ErbB receptor family. Mol. Cell. Biol., 15: 5770-5776, 1995.
31. Alimandi, M., Wang, L. M., Bottaro, D., Lee, C. C., Kuo, A., Frankel, M., Di Fiore, P. P., Tang, C., Lippman, M., and Pierce, J. H. EGF-medialed signal transduction through co-expressed ErbB-2 and ErbB-3 receptors. EMBO J., 16: 5608-5617, 1997.
32. Riese, D. J., II, Bermingham, Y., van Raaij, T. M., Buckley, S., Plowman, G. D., and Stern, D. F. Betacellulin activates the epidermal growth factor receptor and ErbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-β. Oncogene, 12: 345-353, 1996.
33. Kohda, D., Odaka, M., Lax, I., Kawasaki, H., Suzuki, K., Ullrich, A., Schlessinger, J., and Inagaki, F. A 40-kDa epidermal growth factor/transforming growth factor α-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor. J. Biol. Chem., 268: 1976-1981, 1993.
34. Sugawa, N., Ekstrand A. J., James, C. D., and Collins, V. P. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc. Natl. Acad. Sci. USA, 87: 8602-8606, 1990.
35. Yamazaki, H., Ohba, Y., Tamaoki, N., and Shibuya, M. A deletion mutant within the ligand binding domain is responsible for activation of the epidermal growth factor receptor gene in human brain tumors. Jpn. J. Cancer Res., 81: 773-779, 1990.
36. Ekstrand, A. J., Liu, L., He, J., Hamid, M. L., Longo, N., Collins, V. P., and James, C. D. Altered subcellular location of an activated and tumor-associated epidermal growth factor receptor. Oncogene, 10: 1455-1460, 1995.
37. Di Marco, R., Pierce, J. H., Fleming, T. P., Kraus, M. H., Molloy, C. J., Aaronson, S. A., and Di Fiore, P. P. Autocrine interaction between TGF α and the EGF-receptor: quantitative requirements for induction of the malignant phenolype. Oncogene, 4: 831-838, 1989.